Silverback Therapeutics shares owned by Lazard Asset Management
Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by Lazard Asset Management
from 13F filings
Historical chart of Lazard Asset Management investment in Silverback Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Silverback Therapeutics held by Lazard Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Silverback Therapeutics by Lazard Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $167k | 14k | 11.65 |